Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Espinar, Javier Baena
74  Ergebnisse:
Personensuche X
?
1

Correction: Targeting KRASG12C in Non-Small-Cell Lung Cance..:

Torres-Jiménez, Javier ; Espinar, Javier Baena ; de Cabo, Helena Bote...
Drugs.  84 (2024)  5 - p. 619-619 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current S..:

Torres-Jiménez, Javier ; Espinar, Javier Baena ; de Cabo, Helena Bote...
Drugs.  84 (2024)  5 - p. 527-548 , 2024
Link: https://doi.org/10.1007/..
 
?
3

A Multicenter Analysis of the Outcome of Cancer Patients wi..:

Sereno, María ; Jimenez-Gordo, Ana María ; Baena-Espinar, Javier...
Cancers.  13 (2021)  16 - p. 4205 , 2021
Link: https://doi.org/10.3390/..
 
?
4

Subclinical Arteriosclerosis is Associated with Common Vasc..:

Espíldora-Hernández, Javier ; Díaz-Antonio, Tania ; Baena-Espinar, Javier...
Journal of Clinical Medicine.  9 (2020)  4 - p. 971 , 2020
Link: https://doi.org/10.3390/..
 
?
5

A Multicenter Analysis of the Outcome of Cancer Patients wi..:

María Sereno ; Ana María Jimenez-Gordo ; Javier Baena-Espinar...
Cancer Epidemiology and Prevention.  , 2021
Link: https://doi.org/10.3390/..
 
?
6

A Multicenter Analysis of the Outcome of Cancer Patients wi..:

María Sereno ; Ana María Jimenez-Gordo ; Javier Baena-Espinar...
https://www.mdpi.com/2072-6694/13/16/4205.  , 2021
Link: https://doi.org/10.3390/..
 
?
7

Subclinical Arteriosclerosis is Associated with Common Vasc..:

Javier Espíldora-Hernández ; Tania Díaz-Antonio ; Javier Baena-Espinar...
https://www.mdpi.com/2077-0383/9/4/971.  , 2020
Link: https://doi.org/10.3390/..
 
?
8

Subclinical Arteriosclerosis is Associated with Common Vasc..:

Javier Espíldora-Hernández ; Tania Díaz-Antonio ; Javier Baena-Espinar...
Vascular Medicine.  , 2020
Link: https://doi.org/10.3390/..
 
?
9

Trabajo fin de Grado:

Agudo García, María del Carmen ; Aza Blanc, Gonzalo ; Bueno Guerra, Nereida...
E000002462.  , 2019
Link: http://hdl.handle.net/11..
 
?
10

Trabajo fin de Máster:

Aza Blanc, Gonzalo ; Ben-Bouchta del Viejo, Sara ; Berástegui Pedro-Viejo, Ana...
E000004129.  , 2019
Link: http://hdl.handle.net/11..
 
?
11

Formulation strategies to improve the bioavailability of po..:

, In: Dosage Forms, Formulation Developments and Regulations,
Espinar, Francisco Javier Otero ; Lavilla, Carlos Bendicho ; Fernández, Guillermo Blanco.. - p. 223-255 , 2024
Link: https://doi.org/10.1016/..
 
?
12

List of contributors:

, In: Dosage Forms, Formulation Developments and Regulations,
Agnihotri, Tejas Girish ; Ali, Ola Asem Mahmoud Abdou ; Aminu, Nafiu... - p. xxiii-xxviii , 2024
Link: https://doi.org/10.1016/..
 
?
13

Morquio syndrome type A treatment with non-viral vector:

González, José Víctor Álvarez ; Espinar, Francisco Javier Otero ; Lopez, Susana Belen Bravo...
Molecular Genetics and Metabolism.  129 (2020)  2 - p. S20 , 2020
Link: https://doi.org/10.1016/..
 
?
14

MA16.11 Consolidation EGFR-Tyrosine Kinase Inhibitor (TKI)v..:

Nassar, A.H. ; Adib, E. ; Kaldas, D....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S161 , 2023
Link: https://doi.org/10.1016/..
 
?
15

64P Safety and efficacy of immune checkpoint inhibitors (IC..:

Nassar, A.H. ; Zarif, T. ; Abou Alaiwi, S....
Immuno-Oncology and Technology.  16 (2022)  - p. 100169 , 2022
Link: https://doi.org/10.1016/..
 
1-15